Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
Search
Close this search box.
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
Menu
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Human retinal progenitor cells as candidate therapy for retinitis pigmentosa

  • Post author:
  • Post published:May 17, 2025
  • Post category:

The targeted disease is retinitis pigmentosa (RP), is a severe form of blindness that runs in families. This disease is not overly common, yet represents an attainable near term target…

Continue ReadingHuman retinal progenitor cells as candidate therapy for retinitis pigmentosa

Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication

  • Post author:
  • Post published:May 17, 2025
  • Post category:

Leukemia is the most frequent form of cancer in children and teenagers, but is also common in adults. Chemotherapy has vastly improved the outcome of leukemia over the past four…

Continue ReadingDual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication

Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication

  • Post author:
  • Post published:May 17, 2025
  • Post category:

Leukemia is the most frequent form of cancer in children and teenagers, but is also common in adults. Chemotherapy has vastly improved the outcome of leukemia over the past four…

Continue ReadingDual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication

Banking transplant ready dopaminergic neurons using a scalable process

  • Post author:
  • Post published:May 17, 2025
  • Post category:

Parkinson's disease (PD) is a devastating movement disorder caused by the death of dopaminergic neurons (a type of nerve cells in the central nervous system) present in the midbrain. These…

Continue ReadingBanking transplant ready dopaminergic neurons using a scalable process

New Drug Discovery for SMA using Patient-derived Induced Pluripotent Stem Cells

  • Post author:
  • Post published:May 17, 2025
  • Post category:

Spinal muscular atrophy (SMA) is the leading genetic cause of infant death in the U.S. This devastating disease affects 1 child in every 6,000-10,000 live births, with a North American…

Continue ReadingNew Drug Discovery for SMA using Patient-derived Induced Pluripotent Stem Cells

Harnessing native fat-residing stem cells for bone regeneration

  • Post author:
  • Post published:May 17, 2025
  • Post category:

Like most tissues of the body, bone possesses a natural regenerative system aimed at restoring cells and tissues lost to natural cell aging, disease or injury. These natural regenerative systems…

Continue ReadingHarnessing native fat-residing stem cells for bone regeneration

Cartilage Regeneration by the Chondrogenic Small Molecule PRO1 during Osteoarthritis

  • Post author:
  • Post published:May 17, 2025
  • Post category:

The ability to direct the differentiation of resident mesenchymal stem cells (MSCs) towards the cartilage lineage offers considerable promise for the regeneration of articular cartilage after traumatic joint injury or…

Continue ReadingCartilage Regeneration by the Chondrogenic Small Molecule PRO1 during Osteoarthritis

A hESc-based Development Candidate for Huntington’s Disease

  • Post author:
  • Post published:May 17, 2025
  • Post category:

Huntington’s disease (HD) is a devastating degenerative brain disease with a 1 in 10,000 prevalence that inevitably leads to death. These numbers do not fully reflect the large societal and…

Continue ReadingA hESc-based Development Candidate for Huntington’s Disease

Preclinical development of a pan Bcl2 inhibitor for cancer stem cell directed therapy

  • Post author:
  • Post published:May 17, 2025
  • Post category:

Cancer is the leading cause of death for individuals under 85. Relapse and metastatic disease are the leading causes of cancer related mortality. Anti-apoptotic BCL2 family member overexpression has been…

Continue ReadingPreclinical development of a pan Bcl2 inhibitor for cancer stem cell directed therapy
  • Go to the previous page
  • 1
  • 2
  • 3
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us